162 13F filers hold it · −5 against the quarter before · shares held −14.8%
Holdings of 06/30
StocksIs Wall Street adding or cutting?−5
All tracked funds
All 5% stake reports on Heron Therapeutics
Heron Therapeutics HRTX
Health care sectorNasdaq
What to see in Heron Therapeutics now
Company
- Exchange
- Nasdaq
- Sector
- Health care
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, California
- Fiscal year end
- 12/31
- Next earnings
- 11/09, estimated
- 162 13F filers hold it · −5 against the quarter before · shares held −14.8%Holdings of 06/30
Funds
13F filers: 162 · −5 since the quarter before · 06/30 holdings
Famous funds that held Heron Therapeutics in their latest 13F report.
| Fund | Value | Since the quarter before |
|---|---|---|
| Mirae Asset Global ETFS HoldingsHeron Therapeutics HRTX · 06/30 holdings | $31.4K | No quarter before |
5% stakes
| Holder | ||
|---|---|---|
| Vanguard Group03/27 | 0%0 sh | −5.3pp |
| Clearline Capital02/17 | 6.7%12,235,239 sh | +1.4pp |
| Vanguard Group01/30 | 5.35%9,820,384 sh | +0.7pp |
| Clearline Capital25/11/26 | 5.3%9,712,527 sh | First report |
| Rubric Capital Management25/10/17 | 15.9%30,046,828 sh | −1.6pp |
| Rubric Capital Management25/08/12 | 17.5%29,100,728 sh | No earlier report |
